Supriya Lifescience Ltd share price logo

Supriya Lifescience Ltd Share Price

NSE: SUPRIYA

BSE: 543434

Small Cap

Healthcare Sector

₹738.60

+15.95

(+2.21%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Supriya Lifescience Ltd Stock Performance

as on October 17, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹716.3
    ₹742
    downward going graph

    3.02%

    Downside

    0.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹511.4
    ₹842
    downward going graph

    30.76%

    Downside

    14.00%

    Upside

    downward going graph

Supriya Lifescience Ltd share price movements today

Previous Close
₹722.65
Open
₹722.65
Volume
2.56L
Upper Circuit
₹867.15
Lower Circuit
₹578.15
Day's Low - High
₹716.3 - ₹742
52 Week Low - High
₹511.4 - ₹842

Supriya Lifescience Ltd Historical Returns

1 Month Return
+ 7.22 %
3 Month Return
+ 3.84 %
1 Year Return
+ 33.06 %
3 Year Return
+ 155.22 %
5 Year Return
+ 88.97 %

Supriya Lifescience Ltd Fundamentals

as on October 17, 2025 at 4:01 pm IST

Market Cap

₹5,944.46 Cr

Return on Equity (ROE)

20.74

PE Ratio (TTM)

0

Return on capital employed (ROCE)

27.43

Beta (LTM)

1.9

P/B Ratio

5.92

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-22.07

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Supriya Lifescience Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Supriya Lifescience Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Supriya Lifescience Ltd image
Supriya Lifescience Ltd
BUY5,944.4617.79%0.00187696
Venmax Drugs & Pharmaceuticals Ltd image
Venmax Drugs & Pharmaceuticals Ltd
NA13.3357.33%0.00-1NA
Mangalam Drugs and Organics Ltd image
Mangalam Drugs and Organics Ltd
NA111.10-10.14%0.706318
Pharmaids Pharmaceuticals Ltd image
Pharmaids Pharmaceuticals Ltd
NA172.5399.46%0.69-1419
Aarti Drugs Ltd image
Aarti Drugs Ltd
BUY4,759.02-6.59%0.661682,387
See all

Analyst Recommendation on Supriya Lifescience Ltd Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Supriya Lifescience Ltd. Average target price of ₹800

Source: S&P Global Market Intelligence

Supriya Lifescience Ltd Share Price Target

Get share price movements and forecasts by analysts on Supriya Lifescience Ltd.

What analysts predicted

8.31%UPSIDE

Target Price

₹800

Current Price

₹738.6

Analyzed by

1 Analysts

High

₹800

Target

₹800.00

Low

₹800

Supriya Lifescience Ltd target price ₹800, a slight upside of 8.31% compared to current price of ₹738.6. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Supriya Lifescience Ltd Stock’s Investor Sentiment and Interest

Search interest for Supriya Lifescience Ltd Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:74% versus previous 30 day period

Supriya Lifescience Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
105.14
142.27
132.02
140.1
140.07
158.18
160.63
166.1
185.65
184.11
145.07
Other Income
2.56
1.96
2.92
2.47
3.07
2.19
2.22
2.52
2.1
2.98
2.67
Total Income
107.7
144.23
134.94
142.56
143.14
160.37
162.85
168.62
187.75
187.08
147.75
Expenses
91.1
87.22
87.79
108.34
98.59
102.68
98.09
101.39
119.7
116.53
93.37
Operating Profit
14.04
55.05
44.23
31.76
41.48
55.5
62.54
64.71
65.95
67.58
51.7
Operating Profit Margin %
13.35%
38.69%
33.5%
22.67%
29.61%
35.09%
38.93%
38.96%
35.52%
36.71%
35.64%
Profit Before Interest, Tax and Depreciation
16.61
57.01
47.15
34.22
44.55
57.69
64.77
67.24
68.05
70.56
54.38
Interest
1.01
0.71
0.56
0.46
0.49
0.6
0.34
0.43
0.51
0.42
0.51
Depreciation
2.95
3.01
3.96
3.98
3.96
3.91
4.66
4.74
4.96
6.08
6.45
Profit Before Tax
12.65
53.29
42.63
29.78
40.1
53.18
59.77
62.07
62.58
64.06
47.42
Tax Paid
3.12
15.06
14.12
5.9
10.32
16.24
15.13
15.92
15.8
13.68
12.63
Profit After Tax
9.52
38.23
28.51
23.88
29.79
36.93
44.64
46.15
46.78
50.38
34.79
Total Net profit including share of profit / Loss from associate company
9.52
38.23
28.51
23.88
29.79
36.93
44.64
46.15
46.78
50.38
34.79
EPS
1.18
4.75
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
Actual EPS
1.18
4.75
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
Adjusted EPS
1.18
4.75
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
Diluted EPS
1.18
4.75
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32

Supriya Lifescience Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
212.91
277.84
311.64
391.25
530.05
460.94
570.37
696.49
Other Income
8.6
8.02
11.07
4.98
7.58
9.49
10.64
9.82
Total Income
221.51
285.86
322.71
396.22
537.63
470.43
581.01
706.3
Expenses
190.96
213.1
213.26
218.07
316.06
332.04
397.39
435.69
Operating Profit
21.95
64.74
98.38
173.18
213.99
128.9
172.98
260.8
Operating Profit Margin %
10.31%
23.3%
31.57%
44.26%
40.37%
27.96%
30.33%
37.44%
Profit Before Interest, Tax and Depreciation
30.55
72.76
109.45
178.15
221.56
138.39
183.61
270.61
Interest
10.75
10.22
6.85
4.08
4.2
3.08
2.11
1.69
Depreciation
5.33
5.44
6.41
6.76
10.12
11.82
15.81
20.44
Profit Before Tax
14.47
57.1
96.19
167.31
207.24
123.49
165.69
248.48
Tax Paid
5.74
17.68
22.82
43.72
55.44
33.63
46.58
60.53
Profit After Tax
8.73
39.42
73.37
123.59
151.81
89.86
119.11
187.96
Total Net profit including share of profit / Loss from associate company
8.73
39.42
73.37
123.59
151.81
89.86
119.11
187.96
EPS
1.19
5.39
10.03
16.89
18.86
11.16
14.8
23.35
Actual EPS
1.19
5.39
10.03
16.89
18.86
11.16
14.8
23.35
Adjusted EPS
1.19
5.39
2.01
16.89
18.86
11.16
14.8
23.35
Diluted EPS
1.19
5.39
10.03
16.89
18.86
11.16
14.8
23.35

Supriya Lifescience Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
13.5
27.34
27.76
48.88
116.67
75.89
48.8
63.61
113.31
164.68
Cash Flow from Investing Activities
-32.83
-8.57
-4.71
4.83
-25.14
-46.8
-59.82
-123.65
-173.57
-152.24
Cash Flow from Financing Activities
21.36
-2.25
-20.01
-49.92
-29.24
-14.51
149.65
-10.28
-22.36
-8.24
Net Cash Flow
2.03
-1.51
3.03
3.79
62.31
14.57
138.63
-70.33
-82.63
4.2

Supriya Lifescience Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
68.24%
68.28%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
DII
7.89%
7.65%
7.55%
7.17%
3.85%
5.3%
5.48%
5.45%
4.92%
4.26%
4.86%
FII
0%
0%
0%
5.34%
0%
5.36%
4.95%
6.03%
6.52%
7.19%
6.78%
Public
17.63%
18.42%
18.43%
19.19%
21.76%
21.04%
21.27%
20.23%
20.26%
20.26%
20.06%
Total Outstanding Shares
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
Total Shareholders
96,998
95,605
93,478
92,991
95,929
87,980
89,621
85,328
89,394
91,051
91,928

Mutual Funds that own Supriya Lifescience Ltd Stock

Check out the Mutual Funds with significant holdings in Supriya Lifescience Ltd.

Supriya Lifescience Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Supriya Lifescience Ltd.

  • Supriya Lifescience Ltd Earnings Results

    Supriya Lifescience Ltd’s net profit fell -22.07% since last year same period to ₹34.79Cr in the Q1 2025-2026. On a quarterly growth basis, Supriya Lifescience Ltd has generated -30.94% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Supriya Lifescience Ltd Dividends May,2025

    In the quarter ending March 2025, Supriya Lifescience Ltd has declared dividend of ₹1.00 per share on 27 May 2025 - translating a dividend yield of 0.24%.

    Read More about Dividends

Indices Featuring Supriya Lifescience Ltd Stock

Check stock indices that include Supriya Lifescience Ltd.

BSE Healthcare

₹44,905.36

0.5 (▲225.25%)

BSE Small-Cap

₹53,040.96

-0.49 (▲-262.76%)

Insights on Supriya Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.66% to 0.68% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SUPRIYA stock has moved up by 7.2%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SUPRIYA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SUPRIYA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.30% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 20.26% to 20.06% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 7.19% to 6.78% in Jun 2025 quarter

About Supriya Lifescience Ltd

Supriya Lifescience Limited is an Indian manufacturing company and supplier of active pharmaceutical ingredients (APIs). As of 31 March 2021, the company has offered 39 APIs with a focus on therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatics and anti-allergies. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India - 4555 and 6570 units, respectively - between Fiscal 2017 and 2020. Supriya Lifescience has sought approval for its products from international regulatory authorities including the USFDA, EUGMP and EDQM, and is supported by a modern manufacturing facility. Two new clean rooms are set to be powered up in the first quarter of Fiscal 2022. Over the years, the company has issued 3002400, 1626302, 9757804 Equity shares and increased its face value from Rs 10 to Rs 2 per share. In December 2021, Supriya Lifescience Limited conducted a Rs 700 crores public issue and the allotted shares were listed on BSE Ltd and NSE.

Revenue: ₹145.07Cr as on June 2025 (Q1 FY26)
Net Profit: ₹34.79Cr as on June 2025 (Q1 FY26)
Listing date: 28 Dec, 2021
Chairperson Name: Satish Waman Wagh
OrganisationSupriya Lifescience Ltd
IndustryPharmaceuticals
CEOSatish Waman Wagh
E-voting on sharesClick here to vote

FAQs

What is Supriya Lifescience Ltd share price today?

Supriya Lifescience Ltd share price today stands at ₹738.6 as on at the close of the market. Supriya Lifescience Ltd share today touched a day high of ₹742 and a low of ₹716.3.

What is the 52 week high and 52 week low range for Supriya Lifescience Ltd share?

Supriya Lifescience Ltd touched a 52 week high of ₹842 and a 52 week low of ₹511.4. Supriya Lifescience Ltd share price today i.e. is closed at ₹738.6, which is -12.28% down from its 52 week high and 44.43% up from its 52 week low.

What is Supriya Lifescience Ltd's market capitalisation today?

Supriya Lifescience Ltd market capitalisation is ₹5,944.46 Cr as on .

How to buy Supriya Lifescience Ltd shares?

To buy Supriya Lifescience Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUPRIYA or Supriya Lifescience Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Supriya Lifescience Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Supriya Lifescience Ltd trading volume today?

Supriya Lifescience Ltd trading volume is 2.56L as on . This means that 2.56L shares of Supriya Lifescience Ltd were bought and sold on the stock market during today's trading session.